Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "JACC: Basic to Translational Science"
DOI: 10.1016/j.jacbts.2021.09.013
Abstract: COVID-19 is characterized by vascular inflammation and thrombosis, including elevations in P-selectin, a mediator of inflammation released by endothelial cells. We tested the effect of P-selectin inhibition on biomarkers of thrombosis and inflammation in patients… read more here.
Keywords: selectin; selectin inhibitor; crizanlizumab selectin; effect ... See more keywords